organization · Reporting owner
GOLDMAN SACHS GLOBAL HOLDINGS LLC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CORAM HEALTHCARE CORP
Report date December 31, 2002 · Filed May 21, 2003
Jointly reported with GOLDMAN SACHS GROUP INC, GOLDMAN SACHS & CO. LLC, GOLDMAN SACHS CREDIT PARTNERS LP
Section 16 reporting ended · disclosed 2003-05-21. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Series B Convertible Subordinated NotesSEC Table II · derivative / convertible security · Conversion / exercise price $2.00 · Expires 2008-04-15 | IndirectSee footnotes | 0 |
Reported balance
After 2002-12-31 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2002-12-31 · Other · Disposed 0 · Balance 0 F1: Goldman Sachs Credit Partners L.P. (???GS Credit Partners???) may be deemed to own beneficially and directly, and Goldman, Sachs & Co. (???Goldman Sachs???), The Goldman Sachs Group, Inc. (???GS Group???) and Goldman Sachs Global Holdings L.L.C. (???GS Global Holdings???) may be deemed to own beneficially and indirectly, in the aggregate, 2,045,346 shares of Common Stock of Coram Healthcare Corporation (the "Common Stock") by reason of the ownership by GS Credit Partners of $4,090,693 principal amount of Series B Convertible Notes (the "Convertible Notes") of Coram, Inc. issued pursuant to the Securities Exchange Agreement dated May 6, 1998, as amended (the "Securities Exchange Agreement") which are convertible into 2,045,346 shares of Common Stock. Coram, Inc. has the right, in lieu of payment of interest on the Convertible Notes in cash, to pay interest through the issuance of additional Convertible Notes in principal amount equal to the amount of the interest then due and owing. F2: On December 31, 2002, GS Credit Partners and certain other parties to the Securities Exchange Agreement entered into an Exchange Agreement whereby GS Credit Partners exchanged $37,763,507 principal amount of Convertible Notes for 553.73479 shares of Series B Cumulative Preferred Stock of Coram, Inc. As of December 31, 2002, GS Credit Partners, Goldman Sachs, GS Group and GS Global Holdings ceased to be the owners of more than 10% of the shares of the Common Stock reported to be outstanding in the Company's Annual Report on Form 10-K for the period ended December 31, 2002, and are therefore no longer subject to Section 16. F3: GS Group is the 99% owner of GS Global Holdings. GS Global Holdings is the general partner of GS Credit Partners. Goldman Sachs is an indirect wholly-owned subsidiary of GS Group. Goldman Sachs, GS Group and GS Global Holdings each disclaim beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Goldman Sachs Credit Partners L.P. (???GS Credit Partners???) may be deemed to own beneficially and directly, and Goldman, Sachs & Co. (???Goldman Sachs???), The Goldman Sachs Group, Inc. (???GS Group???) and Goldman Sachs Global Holdings L.L.C. (???GS Global Holdings???) may be deemed to own beneficially and indirectly, in the aggregate, 2,045,346 shares of Common Stock of Coram Healthcare Corporation (the "Common Stock") by reason of the ownership by GS Credit Partners of $4,090,693 principal amount of Series B Convertible Notes (the "Convertible Notes") of Coram, Inc. issued pursuant to the Securities Exchange Agreement dated May 6, 1998, as amended (the "Securities Exchange Agreement") which are convertible into 2,045,346 shares of Common Stock. Coram, Inc. has the right, in lieu of payment of interest on the Convertible Notes in cash, to pay interest through the issuance of additional Convertible Notes in principal amount equal to the amount of the interest then due and owing.
F2: On December 31, 2002, GS Credit Partners and certain other parties to the Securities Exchange Agreement entered into an Exchange Agreement whereby GS Credit Partners exchanged $37,763,507 principal amount of Convertible Notes for 553.73479 shares of Series B Cumulative Preferred Stock of Coram, Inc. As of December 31, 2002, GS Credit Partners, Goldman Sachs, GS Group and GS Global Holdings ceased to be the owners of more than 10% of the shares of the Common Stock reported to be outstanding in the Company's Annual Report on Form 10-K for the period ended December 31, 2002, and are therefore no longer subject to Section 16.
F3: GS Group is the 99% owner of GS Global Holdings. GS Global Holdings is the general partner of GS Credit Partners. Goldman Sachs is an indirect wholly-owned subsidiary of GS Group. Goldman Sachs, GS Group and GS Global Holdings each disclaim beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 31, 2002 Filed May 21, 2003 22:30 UTC | CORAM HEALTHCARE CORP CRHEQ · Entity 14180 | OtherSeries B Convertible Subordinated Notes · Derivative | 0 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001209191-03-005186 · bny86848_bny01gsg.xml · derivative · entry 1 GOLDMAN SACHS GROUP INC/ · CIK 0000886982 · Former 10% owner GOLDMAN SACHS & CO · CIK 0000769993 · Former 10% owner GOLDMAN SACHS CREDIT PARTNERS LP · CIK 0001232060 · Former 10% owner GOLDMAN SACHS GLOBAL HOLDINGS LLC · CIK 0001232067 · Former 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Common Stock · 2,045,346 shares Expires 2008-04-15 F1 · security: Goldman Sachs Credit Partners L.P. (???GS Credit Partners???) may be deemed to own beneficially and directly, and Goldman, Sachs & Co. (???Goldman Sachs???), The Goldman Sachs Group, Inc. (???GS Group???) and Goldman Sachs Global Holdings L.L.C. (???GS Global Holdings???) may be deemed to own beneficially and indirectly, in the aggregate, 2,045,346 shares of Common Stock of Coram Healthcare Corporation (the "Common Stock") by reason of the ownership by GS Credit Partners of $4,090,693 principal amount of Series B Convertible Notes (the "Convertible Notes") of Coram, Inc. issued pursuant to the Securities Exchange Agreement dated May 6, 1998, as amended (the "Securities Exchange Agreement") which are convertible into 2,045,346 shares of Common Stock. Coram, Inc. has the right, in lieu of payment of interest on the Convertible Notes in cash, to pay interest through the issuance of additional Convertible Notes in principal amount equal to the amount of the interest then due and owing. F2 · security: On December 31, 2002, GS Credit Partners and certain other parties to the Securities Exchange Agreement entered into an Exchange Agreement whereby GS Credit Partners exchanged $37,763,507 principal amount of Convertible Notes for 553.73479 shares of Series B Cumulative Preferred Stock of Coram, Inc. As of December 31, 2002, GS Credit Partners, Goldman Sachs, GS Group and GS Global Holdings ceased to be the owners of more than 10% of the shares of the Common Stock reported to be outstanding in the Company's Annual Report on Form 10-K for the period ended December 31, 2002, and are therefore no longer subject to Section 16. F3 · security: GS Group is the 99% owner of GS Global Holdings. GS Global Holdings is the general partner of GS Credit Partners. Goldman Sachs is an indirect wholly-owned subsidiary of GS Group. Goldman Sachs, GS Group and GS Global Holdings each disclaim beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein. F2 · kind: On December 31, 2002, GS Credit Partners and certain other parties to the Securities Exchange Agreement entered into an Exchange Agreement whereby GS Credit Partners exchanged $37,763,507 principal amount of Convertible Notes for 553.73479 shares of Series B Cumulative Preferred Stock of Coram, Inc. As of December 31, 2002, GS Credit Partners, Goldman Sachs, GS Group and GS Global Holdings ceased to be the owners of more than 10% of the shares of the Common Stock reported to be outstanding in the Company's Annual Report on Form 10-K for the period ended December 31, 2002, and are therefore no longer subject to Section 16. F2 · shares: On December 31, 2002, GS Credit Partners and certain other parties to the Securities Exchange Agreement entered into an Exchange Agreement whereby GS Credit Partners exchanged $37,763,507 principal amount of Convertible Notes for 553.73479 shares of Series B Cumulative Preferred Stock of Coram, Inc. As of December 31, 2002, GS Credit Partners, Goldman Sachs, GS Group and GS Global Holdings ceased to be the owners of more than 10% of the shares of the Common Stock reported to be outstanding in the Company's Annual Report on Form 10-K for the period ended December 31, 2002, and are therefore no longer subject to Section 16. F1 · price: Goldman Sachs Credit Partners L.P. (???GS Credit Partners???) may be deemed to own beneficially and directly, and Goldman, Sachs & Co. (???Goldman Sachs???), The Goldman Sachs Group, Inc. (???GS Group???) and Goldman Sachs Global Holdings L.L.C. (???GS Global Holdings???) may be deemed to own beneficially and indirectly, in the aggregate, 2,045,346 shares of Common Stock of Coram Healthcare Corporation (the "Common Stock") by reason of the ownership by GS Credit Partners of $4,090,693 principal amount of Series B Convertible Notes (the "Convertible Notes") of Coram, Inc. issued pursuant to the Securities Exchange Agreement dated May 6, 1998, as amended (the "Securities Exchange Agreement") which are convertible into 2,045,346 shares of Common Stock. Coram, Inc. has the right, in lieu of payment of interest on the Convertible Notes in cash, to pay interest through the issuance of additional Convertible Notes in principal amount equal to the amount of the interest then due and owing. F2 · acquired: On December 31, 2002, GS Credit Partners and certain other parties to the Securities Exchange Agreement entered into an Exchange Agreement whereby GS Credit Partners exchanged $37,763,507 principal amount of Convertible Notes for 553.73479 shares of Series B Cumulative Preferred Stock of Coram, Inc. As of December 31, 2002, GS Credit Partners, Goldman Sachs, GS Group and GS Global Holdings ceased to be the owners of more than 10% of the shares of the Common Stock reported to be outstanding in the Company's Annual Report on Form 10-K for the period ended December 31, 2002, and are therefore no longer subject to Section 16. F1 · balance_after: Goldman Sachs Credit Partners L.P. (???GS Credit Partners???) may be deemed to own beneficially and directly, and Goldman, Sachs & Co. (???Goldman Sachs???), The Goldman Sachs Group, Inc. (???GS Group???) and Goldman Sachs Global Holdings L.L.C. (???GS Global Holdings???) may be deemed to own beneficially and indirectly, in the aggregate, 2,045,346 shares of Common Stock of Coram Healthcare Corporation (the "Common Stock") by reason of the ownership by GS Credit Partners of $4,090,693 principal amount of Series B Convertible Notes (the "Convertible Notes") of Coram, Inc. issued pursuant to the Securities Exchange Agreement dated May 6, 1998, as amended (the "Securities Exchange Agreement") which are convertible into 2,045,346 shares of Common Stock. Coram, Inc. has the right, in lieu of payment of interest on the Convertible Notes in cash, to pay interest through the issuance of additional Convertible Notes in principal amount equal to the amount of the interest then due and owing. F1 · ownership.direct: Goldman Sachs Credit Partners L.P. (???GS Credit Partners???) may be deemed to own beneficially and directly, and Goldman, Sachs & Co. (???Goldman Sachs???), The Goldman Sachs Group, Inc. (???GS Group???) and Goldman Sachs Global Holdings L.L.C. (???GS Global Holdings???) may be deemed to own beneficially and indirectly, in the aggregate, 2,045,346 shares of Common Stock of Coram Healthcare Corporation (the "Common Stock") by reason of the ownership by GS Credit Partners of $4,090,693 principal amount of Series B Convertible Notes (the "Convertible Notes") of Coram, Inc. issued pursuant to the Securities Exchange Agreement dated May 6, 1998, as amended (the "Securities Exchange Agreement") which are convertible into 2,045,346 shares of Common Stock. Coram, Inc. has the right, in lieu of payment of interest on the Convertible Notes in cash, to pay interest through the issuance of additional Convertible Notes in principal amount equal to the amount of the interest then due and owing. F2 · ownership.direct: On December 31, 2002, GS Credit Partners and certain other parties to the Securities Exchange Agreement entered into an Exchange Agreement whereby GS Credit Partners exchanged $37,763,507 principal amount of Convertible Notes for 553.73479 shares of Series B Cumulative Preferred Stock of Coram, Inc. As of December 31, 2002, GS Credit Partners, Goldman Sachs, GS Group and GS Global Holdings ceased to be the owners of more than 10% of the shares of the Common Stock reported to be outstanding in the Company's Annual Report on Form 10-K for the period ended December 31, 2002, and are therefore no longer subject to Section 16. F3 · ownership.direct: GS Group is the 99% owner of GS Global Holdings. GS Global Holdings is the general partner of GS Credit Partners. Goldman Sachs is an indirect wholly-owned subsidiary of GS Group. Goldman Sachs, GS Group and GS Global Holdings each disclaim beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein. F1 · ownership.nature: Goldman Sachs Credit Partners L.P. (???GS Credit Partners???) may be deemed to own beneficially and directly, and Goldman, Sachs & Co. (???Goldman Sachs???), The Goldman Sachs Group, Inc. (???GS Group???) and Goldman Sachs Global Holdings L.L.C. (???GS Global Holdings???) may be deemed to own beneficially and indirectly, in the aggregate, 2,045,346 shares of Common Stock of Coram Healthcare Corporation (the "Common Stock") by reason of the ownership by GS Credit Partners of $4,090,693 principal amount of Series B Convertible Notes (the "Convertible Notes") of Coram, Inc. issued pursuant to the Securities Exchange Agreement dated May 6, 1998, as amended (the "Securities Exchange Agreement") which are convertible into 2,045,346 shares of Common Stock. Coram, Inc. has the right, in lieu of payment of interest on the Convertible Notes in cash, to pay interest through the issuance of additional Convertible Notes in principal amount equal to the amount of the interest then due and owing. F3 · ownership.nature: GS Group is the 99% owner of GS Global Holdings. GS Global Holdings is the general partner of GS Credit Partners. Goldman Sachs is an indirect wholly-owned subsidiary of GS Group. Goldman Sachs, GS Group and GS Global Holdings each disclaim beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.